Gasotransmitters are lipid soluble, endogenously produced gaseous signaling molecules that freely permeate the plasma membrane of a cell to directly activate intracellular targets, thus alleviating the need for membrane-bound receptors. The gasotransmitter family consists of three members: nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H 2 S). H 2 S is the latest gasotransmitter to be identified and characterized and like the other members of the gasotransmitter family, H 2 S was historically considered to be a toxic gas and an environmental/ occupational hazard. However with the discovery of its presence and enzymatic production in mammalian tissues, H 2 S has gained much attention as a physiological signaling molecule. Also, much like NO and CO, H 2 S's role in ischemia/reperfusion (I/R) injury has recently begun to be elucidated. As such, modulation of endogenous H 2 S and administration of exogenous H 2 S has now been demonstrated to be cytoprotective in various organ systems through diverse signaling mechanisms. This review will provide a detailed description of the role H 2 S plays in different model systems of I/R injury and will also detail some of the mechanisms involved with its cytoprotection.
(iNOS), responsible for macrophage activation [7] ; and endothelial nitric oxide synthase (eNOS), plays a role in vasorelaxation [8] . Calcium-calmodulin pathways regulate the eNOS and nNOS isoforms whereas iNOS is independent of these actions [9] . When NO is produced it diffuses through the endothelial cell membrane into smooth muscle cells (SMCs) where it activates guanylyl cyclase to produce cyclic guanosine monophospate (cGMP) [10] . Since these discoveries it has been shown that increasing NO by the administration of NO donors [11] , inhaled gas therapy [12] , or overexpression of eNOS protects against ischemic injury (heart, brain, liver, etc.). Preconditioning with NO has also been shown to be protective in cerebral [13] , intestinal [14] , and hepatic [15] ischemia.
Following the discovery of NO as a gasotransmitter, carbon monoxide (CO) was found to have similar roles. CO is formed endogenously by the enzyme heme oxygenase (HO) through the degradation of heme. There are three known isoforms of HO: HO-1, inducible under cellular stress; HO-2, homeostatic form; and HO-3, recently found in rat brain but no gene for HO-3 has yet to been found [16] . HO-1 is responsible for degrading heme into biliverdin and CO. Biliverdin is quickly reduced in the cell to bilirubin, which is a very important antioxidant. Induction of HO-1 through pharmacological agents has been shown to significantly reduce myocardial infarct size in vivo [17] . Yet et al . [18] demonstrated that a cardiac specific HO-1 transgenic mouse is also protected in myocardial ischemia/ reperfusion (MI/R) injury [18] . CO, like NO, is also a known vasodilator through the activation of guanylyl cyclase [19] . However, some evidence suggests calcium-activated potassium channels are targets of CO in the context of vasorelaxation [20] . The cytoprotective effects of CO are also not limited to the heart, as it has been shown that CO contributes to central nervous system mediated blood pressure regulation [21] , protects against pulmonary [22] and renovascular hypertension [23] , modulates atherosclerosis [24] , improves both allograft and xenograft survival following organ transplantation [25] , and exerts a restorative effect on the pathologic remodeling response after balloon angioplasty [26] .
Emergence of H 2 S as the Third Gasotransmitter
The third member of the gasotransmitter family to be identified was hydrogen sulfide (H 2 S), a fetid smelling molecule long thought of as a toxic gas. Warenycia et al [27] first reported that H 2 S was produced in very low concentrations endogenously when they were investigating acute H 2 S poisoning in the brain. Soon after this discovery, evidence of a physiological role of H 2 S began to unravel. Skrajny et al [28] found increased levels of serotonin and reduced levels of norepinephrine in the frontal cortex of a rat when chronically exposed to 20 ppm of H 2 S and in 1996, Abe et al [29] suggested that H 2 S was an endogenous neuromodulator, as they showed that physiological concentrations of H 2 S enhanced NMDA receptor-mediated responses and aided in the induction of hippocampal long-term potentiation. Shortly after, Hosoki et al [30] reported that an enzyme, which produces H 2 S, is present in the ileum, portal vein, and thoracic aorta and proposed that H 2 S may be an endogenous smooth muscle relaxant. Accompanying these discoveries was an interest in the physiological role of H 2 S in biological systems.
Physiological Role of H 2 S in Biological Systems
There are three known enzymes that produce H 2 S endogenously in mammalian tissue: cystathionine β-synthase (CBS), cystathionine γ-lyase (CGL or CSE), and 3-mercaptopyruvate sulfur transferase (3MST). In most tissues, CBS and CSE are responsible for catalyzing the production of H 2 S. CBS and CSE are both pyridoxal-5'-phosphatedependent enzymes that utilize L-cysteine and homocysteine as substrates to liberate ammonium, pyruvate, and H 2 S [1] . It was originally believed that CBS was responsible for H 2 S production in the brain through the activation of the Ca 2+ /calmodulin pathway [31] , but the discovery that approximately 90% of H 2 S in the brain is produced by 3MST [32] has changed the perceived role of CBS in H 2 S production. H 2 S is produced by 3MST from Lcysteine and α-ketoglutarate through the metabolism with cysteine aminotransferase (CAT) [32] . Although 3MST is responsible for the majority of H 2 S production in the brain, it is localized mainly in neurons, whereas CBS is located in astrocytes, suggesting that some H 2 S signaling in the brain may require CBS.
Under physiological conditions, two thirds of H 2 S is dissociated into H + and HS − and the remaining one third is in its undissociated form (H 2 S ⇔ HS − + H + , pKa = 6.9) [33] . There are three major fates of H 2 S in the body. First, most of the H 2 S produced in the body is oxidized in the mitochondria to an end product of sulfate [34] . The remaining H 2 S is either methylated by thiol S-methyltransferase (TSMT) to methanethiol and dimethylsulfide [35] or binds to methemoglobin to form sulfhemoglobin [36] . Sulfate and thiosulfate are the major end product of H 2 S and are excreted in urine [34] .
Cytoprotective Effects of Endogenous/Exogenous H 2 S
The physiological actions of H 2 S make this gas ideally suited to protect the heart, brain, liver, kidney, and lungs against injury during ischemia/reperfusion (I/R). In recent years, the cytoprotective effects of endogenous and exogenous H 2 S have been investigated in models of in vitro [37, 38] and in vivo [39] [40] [41] [42] [43] [44] [45] ischemic injury (summarized in the Table) . The effects of endogenous H 2 S have primarily been studied by pharmacologically inhibiting CGL and by genetically targeting CGL in mice, whereas the effects of exogenous H 2 S have been studied through the administration of H 2 S in the form of sodium hydrosulfide (NaHS), sodium sulfide (Na 2 S), or H 2 S gas.
Cardioprotective Effects of H 2 S
A number of studies have demonstrated the cytoprotective effects of H 2 S in myocardial I/R (MI/R) injury [37, [39] [40] [41] [46] [47] [48] [49] [50] . The first study to show cytoprotection against MI/R injury was Johansen et al [46] who examined the hypothesis that the protective actions of H 2 S are mediated by ATP-sensitive potassium channel (K ATP ) opening. In this study, the authors performed a dose response study using the Lagendorff hanging heart model with rat hearts. They observed an approximate 20% reduction in infarct size when treatment with NaHS (1 µM) was started 10 minutes prior to reperfusion and maintained until 10 min of reperfusion. Using K ATP blockers they also provide evidence to support the involvement of K ATP channel opening as the mechanism of action. Another study executed by Bian et al [37] examined the effect of endogenous H 2 S and exogenous application of NaHS on cardiac rhythm in isolated rat hearts subjected to low-flow ischemia. In this study, NaHS was administered prior to ischemia at a concentration of 100 µM in the perfusate (3 min/each cycle separated by 5 min of recovery). The hearts were then subjected to 30 min of low-flow ischemia followed by 10 min of reperfusion. They found that the NaHS-treated group had a significantly decreased duration and severity of I/R-induced arrhythmias. Isolated rat cardiac myocytes were also investigated using a simulated ischemia solution [i.e., glucose-free Krebs buffer containing 10 mM 2-deoxy-D-glucose (2-DOG) and 10 mM sodium dithionite (Na 2 S 2 O 4 )] and were found to have a significantly increased viability and cell shape when treated with NaHS (10-100 µM). Bliksoen et al. [41] examined the protective effects of H 2 S in global I/R in the heart, the mechanistic role of H 2 S in ischemic preconditioning, and the involvement of protein kinase phosphorylation with H 2 S. In this study, the authors blocked H 2 S production from CSE by using D,L-propargylglycine (PAG) in a Lagendorff perfusion model. A 38% increase in myocardial infarct size was observed after 40 min of low flow ischemia in the PAG-treated (prior to ischemia) hearts when compared to the control hearts. The dramatic increase in infarct size indicates that endogenous H 2 S plays a key role in protecting the heart from MI/R injury. Evidence supporting cardioprotection of both exogenous and endogenous H 2 S has also been observed in vivo. Sivarajah et al. [40] were the first to show that endogenous H 2 S could be protective in myocardial injury. In this study mice were subjected to 25 min of regional myocardial ischemia followed by 2 hr of reperfusion. H 2 S was administered as NaHS (3 mg/kg) 15 min prior to ischemia. A 26% reduction in infarct size was observed in the treated group when compared to the vehicle. Shortly after, Elrod et al. [39] investigated the potential of H 2 S as a cardioprotective agent when given at the time of reperfusion. In this study mice subjected to 30 min of left coronary artery (LCA) ischemia and 24 hr reperfusion displayed a 72% reduction in infarct size when administered H 2 S in the form of Na 2 S (50 µg/kg) at the time of reperfusion. Elrod et al. also tested the cardioprotective effects of endogenous H 2 S by subjecting mice with a cardiac-specific over expression of CGL (about a 2 fold increase in myocardial H 2 S) to MI/ R. After 45 min of left coronary artery occlusion and 72 hr reperfusion, the CGL transgenic mice displayed a 47% reduction in infarct size. This implies that increasing the production of endogenous H 2 S can have similar cardioprotective effects as exogenous H 2 S. Intriguingly inhibition of the endogenous production of H 2 S has also been shown to cause hypertension and diminish endothelium-dependent vasodilatation [51] as well as exacerbates MI/R injury in mice [52] . These in vitro, ex vivo, and in vivo studies clearly show that exogenous and endogenous H 2 S have cardioprotective effects and provide evidence that H 2 S may be a potential therapeutic agent for the treatment of cardiovascular disease.
Neuroprotective Effects of H 2 S
It has been reported that oxidative stress associated with I/R injury causes major damage to neurons [53] . An in vitro study of the efficacy of H 2 S protection against oxidative stress in neurons was performed using glutamate (1mM) and demonstrated that NaHS (100 µM) protects neurons from glutamate toxicity [38] . Kimura et al [54] also suggested that H 2 S may not itself function as an antioxidant in neuronal cells, but instead induces the production of the potent antioxidant glutathione (GSH). Another study on the neuroprotective role of H 2 S was completed on a clonal hippocampal nerve cell line, HT22, using a model of oxidative stress [55] . HT22 cells exposed to glutamate (5 mM) that were treated with NaHS (10-300 µM) showed improved survival over untreated cells. Furthermore, Tyagi et al [56] investigated the effects of H 2 S on methionine (Met)-induced oxidative stress in mouse brain endothelial cells (bEnd3). They found that pre-treatment with NaHS (0.05 and 0.1mM) attenuated cell death as well as peroxynitrite and superoxide anion formation in cells treated with Met (1.14 mM). Further in vivo studies have revealed additional roles of H 2 S in the brain. For example, an elevated level of one of the cerebral substrates of H 2 S, plasma homocysteine (Hcy), is a known risk factor for acute stroke [57] . Qu et al. [58] tested the effect of H 2 S on the development of infarction in rats using a focal cerebral ischemic stroke model by inducing a permanent unilateral occlusion of the left middle cerebral artery (MCA) and found that administration of NaHS (0.18 mmol/kg) 10 min prior to the occlusion increased the infarct volume by approximately 150% compared to the control. Additionally, inhibition of the H 2 S producing enzymes CBS and CSE using pharmacological inhibitors (in order of potency: aminooxyacetic acid [AOAA], hydroxylamine [HA], PAG, β-cyanoalanine [β-CNA]) significantly reduced infarct volume. However more recent studies have shown a protective role for H 2 S in vivo at much lower concentrations. Florian et al [42] examined the effects of H 2 S administered after cerebral ischemia by exposing rats to 2 days of H 2 S gas (80 ppm H 2 S in 19.5% O 2 ). The exposure of H 2 S increased the concentration of H 2 S in the brain from 1.12 ± 4.6 µg/g to 2.70 ± 5.3 µg/g, induced a state of hypothermia (30.8 ± 0.7 °C) and reduced infarct size by 50%. Kimura et al [59] studied the effect of H 2 S on GSH levels in the brains of fetal mice using an intrauterine I/R (5 min/24 hr) model. Intrauterine I/R caused a 24% decrease in GSH levels. However, mice treated with NaHS (0.4375 µmol/kg, i.p.) 15 min before fetal ischemia showed improved fetal brain levels of GSH compared to the untreated mice, suggesting that H 2 S protects by reinstating GSH levels that were lowered during intrauterine I/R. Minamishima et al [60] used a murine model to study the neuroprotective effects of H 2 S (Na 2 S, 0.55 mg/kg) after cardiac arrest/ cardiopulmonary resuscitation (CA/CPR). They observed improved neurological function, decreased activation of the apoptotic protein caspase-3 in the hippocampus, and enhanced phosphorylation (activation) of the anti-apoptotic protein GSK-3β in the brain cortex in mice injected with Na 2 S via a femoral venous line 1 min prior to CPR.
The above studies reveal a variety of neuroprotective roles of H 2 S. In vitro and in vivo studies demonstrate that low concentrations of H 2 S can mediate oxidative stress by restoring GSH levels in the brain, whereas higher concentrations of H 2 S have been shown to have effects that range from magnifying cerebral damage in the ischemic stoke model to inducing a state of neuroprotective. Studies aimed at investigating the role of 3MST in cerebral I/R injury could potentially elucidate the role H 2 S plays in modulating cerebral ischemia.
H 2 S and Hepatoprotection
The cytoprotective effects of H 2 S can also be seen in the liver. Jha et al [43] tested the hepatoprotective effects of H 2 S in a murine model of hepatic I/R by subjecting mice to 60 min of ischemia followed by 5 hr of reperfusion. Na 2 S was administered intravenously 5 min before reperfusion and serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were measured to quantify liver injury. Na 2 S treatments reduced AST levels by 71% and ALT levels by 69% suggesting that H 2 S attenuates hepatic I/R injury. The authors also demonstrated that the hepatoprotective effects of H 2 S were mediated by a decrease in lipid peroxidation levels, an increase in antioxidant signaling, and an increase in anti-apoptotic signaling. While this study provides evidence for exogenous H 2 S therapy it does not address the ability of endogenous H 2 S to affect hepatic injury. Therefore additional studies are warranted to fully elucidate the hepatoprotective effects of H 2 S.
H 2 S and Renal Ischemia
There has been a collection of studies that suggest exogenous and endogenous H 2 S is protective against renal I/R injury. Tripatara et al [44] investigated the effects of endogenous and exogenous H 2 S in renal I/R. They treated rats with PAG (1ml/kg, i.p.) 1 hr before ischemia to inhibit CSE and found that animals displayed increased serum creatine levels signifying a decrease in renal function. Next they performed a bilateral renal occlusion, this time treating the mice with NaHS topically on the kidneys 15 prior to ischemia. A significant increase in renal function was observed, indicating that H 2 S plays a key role in protection against renal ischemia. Xu et al. [45] examined if renal injury was caused by the reduction in activity of CBS in the kidney during I/R by measuring H 2 S and creatine levels after 45 min of renal ischemia and 6 hr of reperfusion. A significant decrease of H 2 S and an increase in plasma creatine levels were observed in the rats subjected to the ischemia, indicating that during ischemia, H 2 S levels drop along with kidney function. The activity of CBS and CGL were also measured in the rats after ischemia; CBS activity levels were significantly decreased while CGL activity was not significantly changed. These data suggest that not only does H 2 S play a role in renal ischemia, but also a major enzyme responsible for H 2 S production is inhibited. Moreover, because CBS is being inhibited, there is an accumulation of Hcy causing a worsening in renal I/R injury [61] .
H 2 S and Pulmonary Ischemia
Only a small number of studies have investigated the role of H 2 S in pulmonary I/R injury. Fu et al [62] explored the potential of H 2 S as a lung protective agent. They measured endogenous H 2 S generation in the rat lung under I/R injury and found that ischemia caused a 46% increase in CSE activity resulting in a 54% increase in H 2 S levels. They also perfused the rat lungs with H 2 S gas (50 µmol/l, 100 µmol/l) 5 min prior to ischemia and found that the pretreated mice displayed pulmonary protection as assessed by lung morphology. H 2 S also decreased I/R-induced lung histological injury, increased lung perfusion flow rate, lowered lung wet/dry weight ratio, and improved lung compliance. Malondialdehyde (MDA) levels were also measured to determine the amount of oxidation in the cells and it was found that H 2 S had significantly lowered MDA levels, suggesting that H 2 S attenuated oxidative stress in the lung.
Limitations of Pharmacological Inhibitors of H 2 S Producing Enzymes
Although multiple pharmacological inhibitors of H 2 S biosynthesis are available, the potency, selectivity, and permeability of the compounds could be challenging when using these inhibitors to suppress a particular H 2 S producing enzyme. PAG and β-CNA are commonly used to inhibit CSE. Unfortunately, they have low potency (25-100 mg/kg) and selectivity in most organs with limited cell membrane permeability [63] . Also, AOAA and HA frequently used inhibitors of CBS, target the pyridoxal-binding site of the enzyme and therefore have the potential of affecting other enzymes in biological systems [64] . Lastly, hydrogen peroxide and tetrathionate are used to inhibit 3MST by interfering with its catalytic cysteine residue. However, many enzymes use cysteines in the catalytic sites and would thus be inhibited by these chemicals [65] . Therefore, there is much room for the development of more specific and potent inhibitors of H 2 S producing enzymes in which could aid in expanding the field's understanding of the endogenous role of H 2 S.
Mechanisms of Action and the Diverse Physiological Profile of H 2 S
It is shown above that H 2 S is protective in many biological systems. The mechanisms through which H 2 S can protect these systems are important to understand in order to utilize its effectiveness as a cytoprotection agent. H 2 S has a wide range of physiological roles in mammalian tissue. In the nervous system, H 2 S has been shown to function as a neuromodulator [29] , modulate NMDA receptors (NMDAR) by inducing the production of cyclic-adenosine monophosphate (cAMP) [66] , and act as an inhibitor of peroxynitrite (ONOO − ) [67] . In the cardiovascular system, numerous roles for H 2 S have been identified: vasorelaxant [68] and antiapoptotic [69] properties by opening of K ATP channels, proangiogenic factor through the phosphorylation of Akt [70] , modulator of leukocytemediated inflammation [71] , upregulator of antioxidant signaling [43] , and involved in cytoprotection through the preservation of mitochondrial function [39] .
K atp Channel -Vasodilation or Calcium Handling
K ATP channels are located on the sarcolemma [72] , the inner mitochondrial membrane [73] , and nuclear membrane [74] and play an important role in glucose metabolism in the cell by membrane hyperpolarization. K ATP channels are composed of two types of subunits: four inwardly rectifying potassium channels K ir 6 (K ir 6.1, K ir 6.2) and four sulfonylurea receptors (SUR1, SUR2A, SUR2B) [75] . K ir 6 subunits form the pore of the channel and are capable of opening and closing to regulate ion flow [73] . SUR receptors are a high affinity receptor sensitive to [ATP/ADP] that facilitates the opening/closing of the K ir 6 subunits [76] and are the target of many pharmacological compounds. It has been proposed that H 2 S-stimulated vasorelaxation occurs through the opening of the K ATP channel [68] . Zhao et al [68] attempted to assess the physiological role of H 2 S in the regulation of vascular contractility, the modulation of H 2 S production in vascular tissues, and the underlying mechanism involved. To achieve this, Zhao et al. gave an intravenous bolus injection of NaHS (2.8 and 14 µmol/kg) to rats and observed a decrease in mean arterial blood pressure similar to an injection of pinacidil (2.8 µmol/kg), a known K ATP channel opener. Supporting this hypothesis, H 2 S has also been shown to increase K ATP channel currents in isolated smooth muscle cells [77] . Cardioprotection, however, may be limited only to specific K ATP channels. In an in vitro study, Bian et al. [37] used the mitochondrial K ATP blocker 5-hydroxydeconoate (5-HD) to demonstrate that mitochondrial K ATP channels were not responsible for the cardioprotective effects of H 2 S. However, they found that inhibition of the sarcolemmal K ATP channels took away the cardioprotective effects of H 2 S. Sivarajah et al. [69] recently performed an in vivo MI/R study to investigate the effect NaHS on infarct size and apoptosis caused by ischemia (25 min) and reperfusion (2 hr). Sivarajah et al. inhibited the mitochondrial K ATP channel with 5-HD and found, contradictory to Bian et al., that H 2 S did not protect the heart when the mitochondrial channel blocker was applied intravenously. These results suggests a new method in studying mitochondrial K ATP channels must be developed to obtain more consistent results before any conclusions can be taken from these experiments.
In MI/R models, Ca 2+ handling is critical in controlling cellular damage. During ischemia, excess Ca 2+ and Na + builds up in the cytosol of the cell [78] . Due to the large [Ca 2+ ] in the cell at the onset of reperfusion, the reoxygenation of the cell causes myofibrils to generate a large amount of force, called hypercontraction [79] . The excessive force irreparably damages the cytoskeleton. Therefore, Ca 2+ handling is essential in controlling reperfusion damage in the cell. Protein kinase C (PKC) has been shown to be involved with Ca 2+ handling and protects against I/R damage. There are three isoforms of PKC in the heart [80] 
H 2 S and Apoptosis
The mechanism behind the cardioprotective effects of H 2 S is not limited to modulation of K ATP channels and Ca 2+ handling. There is much evidence to suggest that H 2 S also has antiapoptotic roles in the cell during M/IR. The activation of two important cell survival pathways, extracellular signal-regulated kinase (ERK1/2)/mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI-3-kinase), can inactivate pro-apoptotic pathways through interaction with PKCε [82] or inhibition of Bad and caspase-9 [83] , respectively. The activation of the ERK1/2 and PI-3-kinase pathways has been found to be influenced by H 2 S [84, 85] . Additionally, activation of the PI-3-kinase/Akt pathway increases the production of the cardioprotective gasotransmitter NO [86] . In an attempt to elucidate the signaling mechanism of H 2 S in the ERK1/2 pathway during cardioprotection, Hu et al [85] found that preconditioning rat myocytes with NaHS (1-100 µM) not only increased cell viability, but that the blockade of ERK1/2 or Akt during preconditioning or ischemia significantly decreased the cardioprotection of H 2 S. Western blot analysis also revealed that H 2 S preconditioning increased the phosphorylation status of ERK1/2 and Akt, further activating the protein's pro-survival mechanisms. Elrod et al [39] performed an in vitro experiment with isolated adult myocytes, which were subjected to 6 hr of hypoxia and 12 hr reoxygenation to further examine the role of H 2 S on apoptotic pathways. They found that myocytes treated with NaHS displayed a decreased activation of caspase-3 and a decrease in the number of nuclei with fragmented DNA (a result of apoptotic signaling cascades). These data suggest that H 2 S inhibited the progression of apoptosis after MI/R injury. Additionally, Sivarajah et al [69] demonstrated that regional MI/R on rat hearts increased the phosphorylation of p38, MAPK, and JNK1/2, pro-apoptotic proteins in the heart, but the administration of NaHS 15 min prior to ischemia significantly reduced the phosphorylation of p38, MAPK, and JNK caused by I/R injury. Cytochrome C, another pro-apoptotic protein, is an essential part of the electron transport chain, but when subjected to pro-apoptotic stimuli, it transports out of the mitochondria into the cytosol. There it activates other apoptotic proteins, including caspase-3, an activator of apoptosis [87] . To determine the effect of H 2 S on the cytochrome C apoptotic pathway during I/R injury, Calvert et al [47] performed a study where mice were given either saline (vehicle) or Na 2 S 24 hr prior to ischemia. After 45 min of ischemia and 24 hr of reperfusion, the tissue isolated from the vehicle treated mice hearts, when compared to sham operated mice, had a significant decrease in the expression of uncleaved caspase-3 (inactive) and a significant increase in the expression of cleaved caspase-3 (active), as well as an induced translocation of cytochrome C from the mitochondria to the cytosol. The mice treated with Na 2 S exhibited a preservation of uncleaved caspase-3, a reduction in cleaved caspase-3, and a reduction in the translocation of cytochrome C to the cytosol (compared to the vehicle treated mice). Therefore, Na 2 S protects the heart tissue from undergoing apoptotic signaling during MI/R.
The Signal Transducers and Activators of Transcription (STAT) pathway has also been shown to be an important part of the myocardium response to myocardial infarction [88] and an overexpression of the STAT isoform STAT-3 has been shown to be cardioprotective [89] . Inhibition of STAT-3 has also been shown to increase caspase-3 expression in the heart, thereby increasing I/R injury [90] . Calvert et al demonstrated in vivo that H 2 S activates PKCε and STAT-3 by altering their phosphorylation, inhibiting the proapoptotic factor Bad, upregulating pro-survival factors Bcl-2 and Bcl-xL, and upregulating heat shock proteins (HSPs) [47] . Therefore, evidence suggests H 2 S has many anti-apoptotic roles in MI/ R.
H 2 S and Mitochondrial Protection
The life of a cell is dependent on the degree of mitochondrial functionality. During I/R, mitochondria are subjected to oxygen deprivation, reactive oxygen species (ROS) overproduction, and mitochondrial membrane potential (ΔΨ m ) depolarization [91] . Roth et al [92] have shown that H 2 S at high levels (80 ppm) can induce a state of hypothermia in mice by inhibiting cytochrome c oxidase, in turn decreasing their metabolic rate and core body temperature. They also showed that inducing this "suspended animation" state can prevent ischemic damage to cells. Elrod et al [39] evaluated potential mechanisms of H 2 Smediated mitochondrial preservation using an in vitro model of Na 2 S treatment. They found that isolated mitochondria, after 30 min of hypoxia, treated with Na 2 S (10 µM) had a greater recovery of posthypoxic respiration rate. Similarly mice that were given Na 2 S at reperfusion displayed a reduction in mitochondrial swelling and an increase in matrix density suggesting preservation in mitochondrial function.
Under myocardial ischemia, the production of ROS is accelerated and all of the cell's antioxidants become depleted. H 2 S is a cytochrome C oxidase inhibitor and therefore inhibits respiration [93] . Inhibition of respiration has been shown to decrease the production of ROS thereby maintaining ΔΨ m [94] . Thus H 2 S, at low concentrations, can decrease the production of ROS and preserve mitochondrial function [52, 95] . Another factor concerning cellular injury is Ca 2+ influx. The Ca 2+ uniporter is the main pathway for Ca 2+ influx [96] during myocardial ischemia. Pan et al [81] demonstrated that H 2 S activates PKC and lowers intracellular [Ca 2+ ] in cardiomyocytes protecting the cells from injury. H 2 S also has the ability to activate other pathways. The PI3K-Akt and Erk 1/2 pro-survival kinase cascades (Reperfusion Injury Salvage Kinase, RISK pathway) are activated during I/R and launches anti-apoptotic responses [97] . A major target of the RISK pathway is the mitochondrial permeability transition pore (mPTP) [97] . Opening of the mPTP occurs during reperfusion and is a terminal cellular event contributing to myocardial injury [96] . H 2 S can overactivate Akt, a major kinase in the RISK pathway [85] . Akt then activates eNOS which evidence suggests inhibits the opening of mPTP [97] . Therefore, H 2 S acts to preserve mitochondrial function, thereby imparting cytoprotection.
H 2 S and Inflammation
Inflammatory responses are an important part of early I/R injury [98] . Li et al [99] investigated the effects of a H 2 S donor, S-diclofenac, on anti-inflammatory activity by administering the proinflammatory bacterial endotoxin lipopolysaccharide (LPS, 10 mg/kg intraperitoneally) to rats, with a group being treated with S-diclofenac (47.2 µmol/kg, i.p.) 60 min prior to LPS injection. They found that the H 2 S donor significantly reduced the rise in plasma concentrations of proinflammatory interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) while also augmenting the rise in plasma concentrations of the antiinflammatory cytokine interleukin-10 (IL-10). Other studies have investigated the pathways that may be involved in the anti-inflammatory effects of H 2 S. After I/R, early inflammatory effects are derived from leukocyte adhesion to endothelial cells [100] . Zanardo et al [71] examined H 2 S as an endogenous regulator of leukocyte-endothelial interactions. They pretreated rats intragastrically with Na 2 S (1-100 µmol/kg) or NaHS (100 µmol/kg) 30 min before administering the leukocyte adhering aspirin and Formyl-Methionyl-LeucylPhenylalanine (fMLP). They found that rats treated with H 2 S dose-dependly decreased leukocyte adherence to endothelial cells. Additionally, Zanardo et al revealed that the rats pretreated with the K ATP channel antagonist glibenclamide did not have a decrease in leukocyte adherence suggesting that the anti-inflammatory effects of H 2 S was through K ATP channel activation. Yusof et al [101] studied the effects of preconditioning with H 2 S on leukocyte rolling (2 nd step in leukocyte-endothelial interactions during ischemia [102] ) and adhesion induced by ischemia. They injected NaHS (14 µmol/kg, i.p.) 24 hr before ischemia, 1 hr before ischemia, and at reperfusion in mice receiving 45 min of superior mesenteric artery ischemia and 60 min reperfusion. They observed that H 2 S initiated latephase preconditioning (tolerance to ischemia 12-24 hr after preconditioning stimulus) and through Western blot analysis revealed a significant increase in phosphorylation (activation) of eNOS and p38 MAPK. These data suggests that the anti-inflammatory effects of preconditioning with H 2 S are eNOS and p38 MAPK pathway dependent since the protective roles of eNOS and p38 MAPK have already been established [103, 104] . More mechanistic studies of H 2 S in inflammation could provide insight into preventing inflammatory tissue damage after I/R.
Summary and Perspective concerning H 2 S in Ischemic Disorders
Whether it is endogenous or exogenous, H 2 S has a wide range of protective functions after I/ R injury throughout the body. Mechanisms of protection include control of intracellular [Ca 2+ ] by stimulating K ATP channel opening, anti-apoptotic pathway (ERK1/2/MAPK, PI-3 kinase/Akt, JAK-STAT) activation, mitochondrial protection through preservation of ΔΨ m and inhibition of mPTP opening, and antiinflammatory effects by activation of eNOS and p38 MAPK. Since the discovery of the cytoprotective effects of H 2 S, developing methods to up-regulate endogenous H 2 S production or provide efficacious treatments of H 2 S donors is becoming a focus of scientists and clinicians alike. Ikaria Holdings Incorporated has two clinical trials beginning based on an H 2 S drug, IK-1001 (Na 2 S). The first ongoing study is the reduction of I/R mediated cardiac injury in patients undergoing coronary artery bypass graft surgery (CABG) to evaluate the capability of IK-1001 as a robust treatment for abbreviating surgical injury. Patients undergoing surgery will receive intravenous infusion for six hours while having the CABG surgery and will be evaluated six months later. The other clinical trial by Ikaria Holdings Inc. that is beginning is a pharmokinetic assessment of Na 2 S in patients with impaired renal function. In this study patients with healthy, mild, and moderately impaired renal function will be injected intravenously with IK-1001 (1.5 mg/kg/ hr) for 3 hours while patients with severely impaired renal function will receive IK-1001 (1.0 mg/kg/hr) for 3 hours intravenously. The patients will then be followed over a sevenday period to investigate any restoration in renal function.
Though H 2 S shows therapeutic potential in I/R injury, an underlying problem with the H 2 S field is that the conventional H 2 S donors, NaHS and Na 2 S, are short acting and do not give a continuous release of H 2 S. Recent studies are suggesting that garlic derivatives could provide an answer to this problem. Garlic has been used for prevention and treatment of atherosclerosis, hyperlipidemia, thrombosis, hypertension, and diabetes [105] . Garlic contains a number of sulfur rich chemical compounds including diallyl disulfide (DADS) and diallyl trisulfide (DATS). Benavides et al [106] conducted a study that demonstrated that DADS and DATS induced H 2 S production and are responsible for the vasoactivity of garlic. However, exhaustive studies demonstrating the protective effects of DADS and DATS in I/R injury have yet to be published.
Although the physiological and cytoprotective effects of H 2 S have been examined, the mechanisms involved are not fully understood. In the past 20 years, H 2 S has come from a reputation as a toxic gas to potentially a therapeutic drug for the treatment I/R injury. Recent research has revealed many beneficial roles for H 2 S in ischemia for a variety of tissues. For example, H 2 S has been shown to be cardioprotective through both endogenous and exogenous applications at or prior to ischemia, neuroprotective via H 2 S-induced hypothermia, hepatoprotective by decreasing lipid peroxidation, increasing antioxidant and anti-apoptotic signaling, renal protective through the actions of CBS, and protective against pulmonary ischemia injury by the activity of CSE. Although much progress has been made in the H 2 S field regarding its physiological roles in different organ systems, there is room still available for more advancement to be made. First, the enzymes responsible for the endogenous production of H 2 S (CBS, CGL, and 3MST) need to be investigated further for other functions and regulatory mechanisms they may have inside biological systems. Knowing an enzyme's specific role and localization in each individual organ system will allow for the targeting of that enzyme to modify endogenous concentrations of H 2 S suitable for the treatment of I/R injury in that tissue. Second, improvement in H 2 S donors could allow for treatments to mimic the endogenous protective effects that H 2 S has in the body. As a result, traditional treatments aimed at combating I/R injury could be challenged with the development of new therapeutic strategies designed capitalize on the potential protective effects of endogenous and exogenous H 2 S. 
